Page last updated: 2024-11-03

risperidone and Mitochondrial Diseases

risperidone has been researched along with Mitochondrial Diseases in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Mitochondrial Diseases: Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, MS1
Sims, KB1
Frazier, JA1

Other Studies

1 other study available for risperidone and Mitochondrial Diseases

ArticleYear
Risperidone-induced psychosis and depression in a child with a mitochondrial disorder.
    Journal of child and adolescent psychopharmacology, 2005, Volume: 15, Issue:3

    Topics: Adolescent; Depressive Disorder; Epilepsy, Tonic-Clonic; Female; Humans; Mitochondrial Diseases; Moo

2005